0001104659-21-133630.txt : 20211103
0001104659-21-133630.hdr.sgml : 20211103
20211103160420
ACCESSION NUMBER: 0001104659-21-133630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211102
FILED AS OF DATE: 20211103
DATE AS OF CHANGE: 20211103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Altarac David
CENTRAL INDEX KEY: 0001792615
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 211375290
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001724344
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824592913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 810-0120
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Entasis Therapeutics Ltd
DATE OF NAME CHANGE: 20171204
4
1
tm2131811-6_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-11-02
0
0001724344
Entasis Therapeutics Holdings Inc.
ETTX
0001792615
Altarac David
C/O ENTASIS THERAPEUTICS HOLDINGS INC.,
35 GATEHOUSE DRIVE
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
Common Stock
2021-11-02
4
F
0
3669
2.94
D
42572
D
Represents shares withheld solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on November 2, 2021. The number of shares withheld was determined based on the closing price on the last trading day prior to vesting, which was November 1, 2021.
Elizabeth M. Keiley as Attorney-in-Fact for David Altarac
2021-11-03